A major advance in cancer research is occurring with the use of nanobodies to reactivate dysfunctional p53. This essential malignant protector protein is frequently disabled in many types of malignancies, leading https://bookmarktune.com/story21836287/vhh-fragments-reactivate-the-p53-protein-the-new-approach-for-cancer-therapy